About Cagent Vascular
Cagent Vascular is a company based in Wayne (United States) founded in 2014 by Robert Giasolli. Cagent Vascular has raised $110.42 million across 7 funding rounds from investors including Trinity Capital, USVP and unknown. Cagent Vascular offers products and services including Serranator and Serranator SL-PRO. Cagent Vascular operates in a competitive market with competitors including Avinger, Pathway Medical Technologies, Intact Vascular, LeMaitre Vascular and Okami Medical, among others.
- Headquarter Wayne, United States
- Founders Robert Giasolli
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$110.42 M (USD)
in 7 rounds
-
Latest Funding Round
$41 M (USD), Series D
May 18, 2026
-
Investors
Trinity Capital
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cagent Vascular
Cagent Vascular offers a comprehensive portfolio of products and services, including Serranator and Serranator SL-PRO.
Balloon for predictable lumen gain in cardiovascular treatments.
Advanced balloon for effective treatment of various lesion morphologies.
People of Cagent Vascular
Unlock access to complete
Funding Insights of Cagent Vascular
Cagent Vascular has successfully raised a total of $110.42M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $41 million completed in May 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cagent Vascular
Cagent Vascular has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Trinity Capital, USVP and unknown.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm that focuses on early stage investments in the US
|
Locked | Locked | Locked | |
|
Sectoral Asset Management is focused on global healthcare investment.
|
Locked | Locked | Locked | |
|
US seed and early-stage startups are funded by Synergy Ventures.
|
Locked | Locked | Locked |
Investor details for Cagent Vascular
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cagent Vascular
Investment portfolio details for Cagent Vascular
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cagent Vascular
Detailed financials for Cagent Vascular
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cagent Vascular Comparisons
Peer comparison for Cagent Vascular
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cagent Vascular
Cagent Vascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avinger, Pathway Medical Technologies, Intact Vascular, LeMaitre Vascular and Okami Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of image-guided catheter-based products for peripheral artery disease
|
|
| Locked | Locked | Locked |
Smart devices are provided to clear peripheral arterial blockages.
|
|
| Locked | Locked | Locked |
Implants for repairing arteries after angioplasty are developed.
|
|
| Locked | Locked | Locked |
Devices for peripheral vascular disease treatment are developed and marketed.
|
|
| Locked | Locked | Locked |
Innovative medical devices for peripheral vessel treatment are developed.
|
Detailed competitors of Cagent Vascular
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cagent Vascular
Complete news archive for Cagent Vascular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cagent Vascular
Cagent Vascular was founded in 2014.
Cagent Vascular is headquartered in Wayne, United States.
Cagent Vascular is a funded company, having raised a total of $110.42M across 7 funding rounds to date.
Cagent Vascular was founded in 2014 in Wayne, United States, and operates in the medical device sector. Focus is placed on the development of a Lesion Preparation balloon, which aids in the effective removal of blockages in blood vessels and enhances drug uptake when combined with drug-coated balloons. Applications target the treatment of peripheral arterial disease, with ongoing efforts in vascular intervention technologies.
Cagent Vascular's top competitors include Avinger, Okami Medical and LeMaitre Vascular.
Cagent Vascular offers Serranator and Serranator SL-PRO.
Cagent Vascular has 6 investors. Key investors include Trinity Capital, USVP, unknown, Sectoral Asset Management, and Synergy Ventures.